Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
Introduction Myasthenia gravis (MG) is an autoimmune disease characterized by dysfunction at the neuromuscular junction. Treatment frequently includes corticosteroids (CSs) and IV immunoglobulin (IVIG). Treatment of severe MG or exacerbations frequently includes plasma exchange or IV immunoglobulin (IVIG). Plasma exchange was shown to improve muscle strength in patients with MG. Treatment with IVIG was found to produce […]
Prevalence of depression and anxiety among myasthenia gravis (MG) patients: A systematic review and meta-analysis
Introduction In MG, the transmission of nerve impulses to the muscles is disrupted. When there is no nerve–muscle connection, muscles are disrupted and cause neuromuscular disorders in these patients. Myasthenia gravis (MG) people experience adverse psychiatric outcomes, which may impact on their life and disturb their daily activity. Depression and anxiety are identified as significant […]